Skip to main content

For questions about financial assistance, call 1-844-DUPIXENT, option 1 or
click to learn more  

DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.

DUPIXENT
FOR KIDS

LILA,
Actual DUPIXENT patient

since 2022.

Individual results may vary.

IS DUPIXENT RIGHT FOR YOUR CHILD?

If your child's uncontrolled, moderate-to-severe eczema keeps coming back, despite prescription topicals, it may be time to consider a targeted treatment like DUPIXENT. Signs it may be time:

  • Itchy, uncomfortable skin
  • Random and constant flare-ups
  • Hiding skin because of eczema
  • Missing school or activities because of eczema

DUPIXENT can help control your child’s symptoms by:

Targeting a key source of underlying inflammation that can cause eczema
Continuously treating eczema, even between flare-ups
Helping them stay ahead of eczema with clearer skin and less itch

Clearer Skin and Less Itch for Teens

Slide to see the difference in a real teen patient.

Actual 12-year-old clinical trial patient treated with DUPIXENT. This patient did not meet clinical trial criteria for clear or almost clear skin at 16 weeks. Individual results may vary.

Click and drag
to see results
dragging icon

Before Treatment

After Treatment with
dupixent at 16 weeks

View study results in teens

Long-term safety: a year-long study in pediatrics

Long-term safety results in teens aged 12 to 17 continuing on DUPIXENT through 1 year in the pediatric extension study were consistent with the adult clinical trials.

Most Common Side Effects in Patients With Eczema Include:

  • Injection site reactions
  • Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects. Your most important partner in your teenager’s treatment is their doctor. Have open conversations with them to address any questions or concerns.

More Kids Saw Relief

Slide to see the before and after photos of real pediatric patients aged 6 to 11 years.

Actual 10-year-old (top) and 9-year-old (bottom) clinical trial patients treated with DUPIXENT and a topical corticosteroid. These patients met clinical trial criteria for clear or almost clear skin. Individual results may vary.

Click and drag
to see results
dragging icon

Before
Treatment

After treatment
with dupixent
at 16 weeks

Click and drag
to see results
dragging icon

Before
Treatment

After treatment
with dupixent
at 16 weeks

View results in children

Long-term safety: a year-long study in pediatrics

Long-term safety results in children aged 6 to 11 continuing on DUPIXENT with or without topical corticosteroids through 1 year in the pediatric extension study were consistent with the adult clinical trials.

Most Common Side Effects in Patients With Eczema Include:

  • Injection site reactions
  • Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects. Your most important partner in your child's treatment is their doctor. Have open conversations with them to address any questions or concerns.

Proven ECZEMA Relief From Infancy On (ages 6 monthS+)

Slide to see the difference DUPIXENT made in a 4-year-old patient.

Actual 4-year-old clinical trial patient treated with DUPIXENT and a topical corticosteroid. This patient met clinical trial criteria for clear or almost clear skin. Individual results may vary.

Click and drag
to see results
dragging icon

Before
Treatment

AFTER TREATMENT
With
DUPIXENT at
16 Weeks

View results in young children

Long-term safety: a year-long study in pediatrics

Long-term safety results in infants and young children aged 6 months to 5 years continuing on DUPIXENT with or without topical corticosteroids through 1 year in the pediatric extension study were consistent with the adult clinical trials. In addition, hand-foot-and-mouth disease and warts were reported. In these reported cases, patients continued treatment with DUPIXENT.

Most Common Side Effects in Patients With Eczema Include:

  • Injection site reactions
  • Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects. It is important to talk to your young child's pediatrician or eczema specialist about any and all side effects they experience. Don’t hesitate to bring up any concerns or questions you may have.

Clearer Skin and Less Itch for Teens

Slide to see the difference in a real teen patient.

Actual 12-year-old clinical trial patient treated with DUPIXENT. This patient did not meet clinical trial criteria for clear or almost clear skin at 16 weeks. Individual results may vary.

Click and drag
to see results
dragging icon

Before Treatment

After Treatment with
dupixent at 16 weeks

View study results in teens

Long-term safety: a year-long study in pediatrics

Long-term safety results in teens aged 12 to 17 continuing on DUPIXENT through 1 year in the pediatric extension study were consistent with the adult clinical trials.

Most Common Side Effects in Patients With Eczema Include:

  • Injection site reactions
  • Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects. Your most important partner in your teenager’s treatment is their doctor. Have open conversations with them to address any questions or concerns.

More Kids Saw Relief

Slide to see the before and after photos of real pediatric patients aged 6 to 11 years.

Actual 10-year-old (top) and 9-year-old (bottom) clinical trial patients treated with DUPIXENT and a topical corticosteroid. These patients met clinical trial criteria for clear or almost clear skin. Individual results may vary.

Click and drag
to see results
dragging icon

Before
Treatment

After treatment
with dupixent
at 16 weeks

Click and drag
to see results
dragging icon

Before
Treatment

After treatment
with dupixent
at 16 weeks

View results in children

Long-term safety: a year-long study in pediatrics

Long-term safety results in children aged 6 to 11 continuing on DUPIXENT with or without topical corticosteroids through 1 year in the pediatric extension study were consistent with the adult clinical trials.

Most Common Side Effects in Patients With Eczema Include:

  • Injection site reactions
  • Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects. Your most important partner in your child's treatment is their doctor. Have open conversations with them to address any questions or concerns.

Proven ECZEMA Relief From Infancy On (ages 6 monthS+)

Slide to see the difference DUPIXENT made in a 4-year-old patient.

Actual 4-year-old clinical trial patient treated with DUPIXENT and a topical corticosteroid. This patient met clinical trial criteria for clear or almost clear skin. Individual results may vary.

Click and drag
to see results
dragging icon

Before
Treatment

AFTER TREATMENT
With
DUPIXENT at
16 Weeks

View results in young children

Long-term safety: a year-long study in pediatrics

Long-term safety results in infants and young children aged 6 months to 5 years continuing on DUPIXENT with or without topical corticosteroids through 1 year in the pediatric extension study were consistent with the adult clinical trials. In addition, hand-foot-and-mouth disease and warts were reported. In these reported cases, patients continued treatment with DUPIXENT.

Most Common Side Effects in Patients With Eczema Include:

  • Injection site reactions
  • Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects. It is important to talk to your young child's pediatrician or eczema specialist about any and all side effects they experience. Don’t hesitate to bring up any concerns or questions you may have.

PIXI & ALEX'S ADVENTURE

Find tips, tools, and even a fun storybook about moderate-to-severe eczema to help you and your child navigate their journey on DUPIXENT.

SUPPORT FOR CAREGIVER AND PATIENT

Our patient support program offers resources to help support you and your child throughout the treatment journey, including financial assistance options.

STAY INFORMED

Stay up to date with helpful information and resources for treating your child with DUPIXENT.

STARTING TREATMENT WITH DUPIXENT

DUPIXENT is an injectable medicine that is not taken every day. Your child's doctor will determine the dose for your child based on their age and weight.